Future Outlook and Growth Opportunities in the Generic Drugs Market
The global generic drugs market is projected to grow significantly, with an estimated increase from USD 439.37 billion in 2022 to USD 738.53 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from 2023 to 2032. This growth is driven by a surge in generic drug approvals and an overall boost in investments within the generic drug sector.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5053
The Role of Off-Patent, Off-Exclusivity Drugs in the Generic Drugs Market
Off-patent and off-exclusivity drugs refer to pharmaceutical products that have lost their patent protection or exclusivity rights. This means that other manufacturers can produce and sell generic versions of these drugs. Generic drugs are typically more affordable than their brand-name counterparts and provide similar therapeutic effects. The availability of off-patent and off-exclusivity drugs contributes to increased accessibility to essential medications and competition in the pharmaceutical market.
The FDA publishes a list of approved new drug application (NDA) products that lost patent protection or exclusivity without an approved abbreviated new drug application (ANDA). The list is updated every six months to promote transparency and encourage competition in markets with limited alternatives.
Introduction
- Research Objective
- Scope of the Study
- Definition and Taxonomy
Research Methodology
- Research Approach
- Data Sources
- Assumptions
Executive Summary
- Synopsis
- Analyst Recommendations
Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Value Chain Analysis
- Raw Material Sourcing
- Manufacturing Process
- Logistics & Transportation
- Buyer Preferences
- Trends
- Market Trends
- Technological Trends
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitute
- Threat of New Entrants
- Degree of Competition
- PESTLE Analysis for 5 Leading Countries
- Regulatory Framework for Leading Countries/Regions
- Supply Demand Analysis
- Production & Consumption Statistics
- Export Import Statistics
- Price Trend Analysis
Global Generic Drugs Market Assessment
- Overview
- Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
- Simple Generics
- Super Generics
- Complex Generics
- Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
- Oral
- Injectable
- Demal and Inhaler
- Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
- Oncology
- Central Nervous system
- Systemic Anti-infectives
- Gastrointestinal
- Cardiovascular
- Musculoskeletal
- Others
- Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
- North America
- Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
North America Generic Drugs Market Assessment
- Overview
- North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
- Simple Generics
- Super Generics
- Complex Generics
- North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
- Oral
- Injectable
- Demal and Inhaler
- North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
- Oncology
- Central Nervous system
- Systemic Anti-infectives
- Gastrointestinal
- Cardiovascular
- Musculoskeletal
- Others
- North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
Europe Generic Drugs Market Assessment
- Overview
- Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
- Simple Generics
- Super Generics
- Complex Generics
- Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
- Oral
- Injectable
- Demal and Inhaler
- Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
- Oncology
- Central Nervous system
- Systemic Anti-infectives
- Gastrointestinal
- Cardiovascular
- Musculoskeletal
- Others
- Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Europe Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
Asia-Pacific Generic Drugs Market Assessment
- Overview
- Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
- Simple Generics
- Super Generics
- Complex Generics
- Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
- Oral
- Injectable
- Demal and Inhaler
- Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
- Oncology
- Central Nervous system
- Systemic Anti-infectives
- Gastrointestinal
- Cardiovascular
- Musculoskeletal
- Others
- Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Asia-Pacific Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
Latin America Generic Drugs Market Assessment
- Overview
- Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
- Simple Generics
- Super Generics
- Complex Generics
- Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
- Oral
- Injectable
- Demal and Inhaler
- Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
- Oncology
- Central Nervous system
- Systemic Anti-infectives
- Gastrointestinal
- Cardiovascular
- Musculoskeletal
- Others
- Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Latin America Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
- Brazil
- Rest of Latin America
Middle East & Africa (MEA) Generic Drugs Market Assessment
- Overview
- Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
- Simple Generics
- Super Generics
- Complex Generics
- Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
- Oral
- Injectable
- Demal and Inhaler
- Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
- Oncology
- Central Nervous system
- Systemic Anti-infectives
- Gastrointestinal
- Cardiovascular
- Musculoskeletal
- Others
- Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Middle East & Africa (MEA) Generic Drugs Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Company Profiles
- Mylan N.V.
- Company Overview
- Geographic Footprints
- Financial Performance
- Product Portfolio
- SWOT Analysis
- R&D Efforts
- Recent Developments & Strategic Collaborations
- Product Launch/M&A/Technical Collaboration
- Abbott Laboratories
- ALLERGAN
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- STADA Arzneimittel AG
- GlaxoSmithKline Plc.
- Baxter International Inc.
- Pfizer Inc.
- Sandoz International GmbH
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/generic-drugs-market
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5053
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Visit Dental Specifics: https://www.towardsdental.com
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare